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Optics of the future

Diary of a cataract surgeon 2045
Claire McDonnell imagines cataract surgery 30 years into the future

Battery powered
My next patient finally shows. He is
in his early 40s and has no significant
lens opacification but he is beginning
to struggle with close work and
wants his vision restored to that of
his pre-presbyopic days. I talk him
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Image Broker/Rex
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y first patient of
the day is a recently
retired 80-year-old
woman who had
been using topical
antioxidants
for the last 10 years to delay lens
opacification,1-8 but she was recently
required by police to take an eyesight
test having driven into the exit lane
of a tunnel. She passed the acuity test
but did not meet the ocular straylight
and contrast sensitivity standards and
therefore she is obliged to undergo
cataract surgery.
We discuss various options and in
the end she chooses the budget option
of a bag-in-the-lens multifocal IOL. I
explain to her that the corneal incisions,
the anterior and posterior capsulotomies
and the nucleus chop will be done by
an optometrist operating a femtosecond
laser and that I will then step in to do
the lens removal and IOL implantation.
She asks if the implant can be replaced
if she does not have perfect vision
postoperatively. I explain that the power
of IOL required will be calculated
based on readings taken during surgery
and the IOL will then be 3D printed9
and sterilised before being implanted so
the likelihood of her having less-thanperfect vision is minimal.
My next patient is late and so I
reflect a little on how cataract surgery
has changed in the past 30 years.
Bag-in-the-lens implantation has
virtually eliminated posterior capsule
opacification and although it was
first conceived in the early 2000s,
it only really became widespread
when femtosecond laser-assisted
anterior and posterior capsulotomies
made the procedure less surgically
demanding.10,11 Optometrists and (in
some countries) nurses became more
heavily involved in cataract surgery as
the size of the elderly population grew
and the number of ophthalmologists
available to carry out surgery was
inadequate for the large patient
numbers.12

Phacoemulsification in progress

through acufocus IOLs explaining
that they are made from birefringent
crystals and that their focus can be
changed from distance to intermediate
to near, by running an electrical charge
through them.13 They are powered
using biothermal batteries14 which
use the body’s own heat for power and
the change in focus is triggered based
on feedback from sensors attached to
the ciliary muscle. He is happy to go
ahead with these implants but decides
against going for the premium option
lenses which include crystals that can
change polarisation and therefore act as
internal sunglasses.
My next patient cannot afford
acufocus implants but does not
want multifocals so we discuss
another procedure: phaco-ersatz.15
The optometrist will create a
tiny capsulorrhexis with the
femtosecond laser and I will carry out
phacoemulsification and lens removal
with micro-instruments. The capsular
bag is then filled with a silicon polymer
containing an antimetabolite to prevent
posterior capsule opacification.16-18
The polymer is cured but still retains
a Young’s modulus similar to the
eye’s natural lens and so allows the
lens to change shape in response
to tension on the lens zonules thus
restoring accommodation.19 I take
capsular volume measurements from
the patient’s eyes to check if I can
make her emetropic in the distance
postoperatively but the machine
calculates that she will be approximately
-3D myopic in both eyes. However, I
see from her medical records (which I
access once I complete her iris scan20)
that she wears contact lenses, as that is
the method used to both monitor her

glaucoma and deliver medication to her
eyes, therefore the correction of any
residual refractive error can be achieved
using the lenses.21,22
Look, no hands
In the afternoon I have surgery in one
of our outreach theatres. I remain in our
main office and I perform the surgery
remotely. I watch the surgery live on
camera and robotic hands (with haptic
feedback) copy the movements of my
own hands which are operating in
special gloves.23 The on-site nurses look
after everything else. There was once
a hope that this kind of surgery could
be used in poorer countries with few
trained surgeons, but high equipment
costs and a lack of qualified technicians
to service the equipment meant that
this idea was never realised. Another
disadvantage is the fact that there is
extra training required to become a
remote-hands surgeon compared to that
of a real-hands-only surgeon.
Later that day as I drive home from
work I listen to a medical podcast
and I hear an interesting piece about
an ophthalmologist in the Middle
East who has carried out cosmetic
refractive lens exchange on a patient.
The surgeon has implanted an IOL
containing a diamond into a patient’s
eyes. Because the refractive index of
diamond is so much higher than that of
the aqueous and vitreous, it has created
a very strong Purkinje image which
gives the appearance of a ‘twinkle’ in
each eye. I marvel at people’s vanity
and wonder to myself if the world has
gone completely mad. ●
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